Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neonmind Biosciences Inc (NEON.CN)

Neonmind Biosciences Inc (NEON.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,005
  • Shares Outstanding, K 125,065
  • Annual Sales, $ 416 K
  • Annual Income, $ -2,677 K
  • 60-Month Beta N/A
  • Price/Sales 23.17
  • Price/Cash Flow N/A
  • Price/Book 22.88
Trade NEON.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.070 +7.14%
on 12/07/21
0.125 -40.00%
on 11/15/21
-0.030 (-28.57%)
since 11/08/21
3-Month
0.070 +7.14%
on 12/07/21
0.140 -46.43%
on 09/28/21
-0.050 (-40.00%)
since 09/08/21

Most Recent Stories

More News
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

VANCOUVER, BC / ACCESSWIRE / December 2, 2021 / NeonMind Biosciences Inc. (CSE:NEON) (OTCQB:NMDBF) (FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company focused...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001

- FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for sustainable weight loss - Company plans to file an IND...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021

VANCOUVER, BC / ACCESSWIRE / November 17, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, is pleased...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments

VANCOUVER, BC / ACCESSWIRE / November 8, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind'' or the "Company"), an integrated drug development and wellness company, today announced...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine

Announces Participation in Microdose's Wonderland: Miami on November 8-9, 2021 VANCOUVER, BC / ACCESSWIRE / November 5, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind"), an...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
Psychedelics Could Alter a Potential $2.5 Trillion Mental Health Market

Psychedelics could soon revolutionize the $2.5 trillion mental health market. In fact, according to ...

CYBN : 1.2194 (-6.20%)
CLXPF : 3.0200 (-1.31%)
FTRP.TO : 4.03 (-0.25%)
FTRP : 3.19 (unch)
MCURF : 0.1700 (+5.13%)
ATAI : 11.33 (+1.34%)
NMDBF : 0.0602 (+0.33%)
FTRP.CN : 5.550 (+1.46%)
MCUR.CN : 0.220 (+7.32%)
NEON.CN : 0.075 (+7.14%)
NeonMind Advances Strategy for Specialty Clinic Launch

Company expects to launch first specialty clinic locations by early 2022 NeonMind-branded specialty mental health clinics to bring innovative interventional psychiatry treatments to underserved populations...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.

Company Continues to Expand Its Scientific Expertise with Noted Expert in Utilizing Ketamine for Treatment Resistant Depression VANCOUVER, BC / ACCESSWIRE / September 22, 2021 / NeonMind Biosciences Inc....

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board

Company Broadens Scientific Expertise with Addition of Mental Health Expert in Setting Up and Managing Interventional Psychiatric Clinics VANCOUVER, BC / ACCESSWIRE / September 16, 2021 / NeonMind Biosciences...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets

Reflects Strategic Focus on Psychedelic Treatments with Major Milestones in 2021 VANCOUVER, BC / ACCESSWIRE / September 13, 2021 / NeonMind Biosciences Inc. (CSE:NEON)(OTCQB:NMDBF)(FRA:6UF) ("NeonMind",...

NEON.CN : 0.075 (+7.14%)
NMDBF : 0.0602 (+0.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 0.087
2nd Resistance Point 0.083
1st Resistance Point 0.077
Last Price 0.075
1st Support Level 0.067
2nd Support Level 0.063
3rd Support Level 0.057

See More

52-Week High 0.350
Fibonacci 61.8% 0.243
Fibonacci 50% 0.210
Fibonacci 38.2% 0.177
Last Price 0.075
52-Week Low 0.070

See More

Business Summary

NeonMind Biosciences Inc is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The company operates three divisions: a pharmaceutical division engaged in drug development...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar